Table 3 Cumulative frequency of major side effects during the 3-month treatment period by study group
| Â | Standard Practice (N = 104) | Polypill (N = 99) | Odds ratio (95% CI) | p-value |
|---|---|---|---|---|
Epigastric pain | 20/104 (19.2%) | 15/97 (15.5%) | 1.30 (0.62, 2.72) | 0.482 |
Musculoskeletal pain | 29/104 (27.9%) | 26/97 (26.8%) | 1.06 (0.57, 1.96) | 0.864 |
Cough | 18/104 (17.3%) | 25/97 (25.8%) | 0.60 (0.30, 1.19) | 0.144 |
Other symptoms | 12/104 (11.5%) | 15/97 (15.5%) | 0.71 (0.32, 1.61) | 0.415 |